Effect of structural modification on antitumor activity of haloacetylphenothiazines.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use* / Q000633:toxicity; D005260:Female; D007928:Lethal Dose 50; D051379:Mice; D009368:Neoplasm Transplantation; D010640:Phenothiazines / Q000627:therapeutic use* / Q000633:toxicity; D012510:Sarcoma 180 / Q000188:drug therapy*; D013329:Structure-Activity Relationship
D000970:Antineoplastic Agents; D010640:Phenothiazines